{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Humira%C2%AE&page=2", "query": { "intervention": "Humira®", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Humira%C2%AE&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-21T07:45:33.369Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02480153", "title": "A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02).", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "PF-06410293", "type": "BIOLOGICAL" }, { "name": "Adalimumab", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 597, "start_date": "2015-06-25", "completion_date": "2017-12-06", "has_results": true, "last_update_posted_date": "2019-01-23", "last_synced_at": "2026-09-21T07:45:33.369Z", "location_count": 49, "location_summary": "Gilbert, Arizona • Glendale, Arizona • Phoenix, Arizona + 43 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Fullerton", "state": "California" }, { "city": "San Leandro", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02480153" }, { "nct_id": "NCT02019472", "title": "A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Arthritis, Rheumatoid" ], "interventions": [ { "name": "adalimumab 40 mg", "type": "BIOLOGICAL" }, { "name": "sirukumab 100 mg", "type": "BIOLOGICAL" }, { "name": "sirukumab 50 mg", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 559, "start_date": "2014-04-04", "completion_date": "2016-08-17", "has_results": true, "last_update_posted_date": "2017-10-26", "last_synced_at": "2026-09-21T07:45:33.369Z", "location_count": 42, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Arvin, California + 39 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Arvin", "state": "California" }, { "city": "El Cajon", "state": "California" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02019472" }, { "nct_id": "NCT02260791", "title": "A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Arthritis, Rheumatoid" ], "interventions": [ { "name": "FKB327", "type": "DRUG" }, { "name": "Humira®", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Fujifilm Kyowa Kirin Biologics Co., Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 728, "start_date": "2014-12", "completion_date": "2016-07", "has_results": true, "last_update_posted_date": "2017-11-28", "last_synced_at": "2026-09-21T07:45:33.369Z", "location_count": 16, "location_summary": "Peoria, Arizona • Palm Desert, California • Boca Raton, Florida + 13 more", "locations": [ { "city": "Peoria", "state": "Arizona" }, { "city": "Palm Desert", "state": "California" }, { "city": "Boca Raton", "state": "Florida" }, { "city": "Brandon", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02260791" }, { "nct_id": "NCT02744755", "title": "Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Adalimumab - GP2017", "type": "BIOLOGICAL" }, { "name": "Adalimumab - US licensed Humira", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sandoz", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 353, "start_date": "2016-03-31", "completion_date": "2017-09-26", "has_results": true, "last_update_posted_date": "2018-12-19", "last_synced_at": "2026-09-21T07:45:33.369Z", "location_count": 30, "location_summary": "Mesa, Arizona • Peoria, Arizona • Covina, California + 25 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Covina", "state": "California" }, { "city": "Hemet", "state": "California" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02744755" }, { "nct_id": "NCT02207244", "title": "A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriasis" ], "interventions": [ { "name": "Guselkumab 100 mg", "type": "DRUG" }, { "name": "Placebo for guselkumab", "type": "DRUG" }, { "name": "Adalimumab", "type": "DRUG" }, { "name": "Placebo for adalimumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 992, "start_date": "2014-11-03", "completion_date": "2020-07-01", "has_results": true, "last_update_posted_date": "2021-07-22", "last_synced_at": "2026-09-21T07:45:33.369Z", "location_count": 32, "location_summary": "Birmingham, Alabama • Bakersfield, California • Los Angeles, California + 29 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Bakersfield", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Santa Monica", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02207244" }, { "nct_id": "NCT03210259", "title": "The VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriasis" ], "interventions": [ { "name": "Humira®", "type": "DRUG" }, { "name": "BI 695501", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 259, "start_date": "2017-07-10", "completion_date": "2019-04-16", "has_results": true, "last_update_posted_date": "2021-07-14", "last_synced_at": "2026-09-21T07:45:33.369Z", "location_count": 21, "location_summary": "Birmingham, Alabama • Encinitas, California • Los Angeles, California + 17 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Encinitas", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sherman Oaks", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03210259" }, { "nct_id": "NCT01295814", "title": "Efficacy Study of Adalimumab to Treat Interstitial Cystitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Interstitial Cystitis" ], "interventions": [ { "name": "Adalimumab", "type": "DRUG" }, { "name": "inactive drug", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "ICStudy, LLC", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 43, "start_date": "2011-03", "completion_date": "2013-07", "has_results": true, "last_update_posted_date": "2015-07-16", "last_synced_at": "2026-09-21T07:45:33.369Z", "location_count": 1, "location_summary": "Escondido, California", "locations": [ { "city": "Escondido", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01295814" }, { "nct_id": "NCT01848561", "title": "A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Ulcerative Colitis (UC)" ], "interventions": [], "intervention_types": [], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 8250, "start_date": "2013-04-29", "completion_date": "2028-06", "has_results": false, "last_update_posted_date": "2025-07-16", "last_synced_at": "2026-09-21T07:45:33.369Z", "location_count": 169, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 131 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT01848561" }, { "nct_id": "NCT00055497", "title": "Remission in Subjects With Crohn's Disease, 1 Year Phase", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Crohn's Disease" ], "interventions": [ { "name": "Double-blind (DB) adalimumab placebo", "type": "BIOLOGICAL" }, { "name": "DB adalimumab 40 mg eow", "type": "BIOLOGICAL" }, { "name": "DB adalimumab 40 mg ew", "type": "BIOLOGICAL" }, { "name": "OL adalimumab 40 mg", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Abbott", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 276, "start_date": "2002-08", "completion_date": "2008-12", "has_results": true, "last_update_posted_date": "2011-04-11", "last_synced_at": "2026-09-21T07:45:33.369Z", "location_count": 43, "location_summary": "Berkeley, California • Long Beach, California • San Diego, California + 36 more", "locations": [ { "city": "Berkeley", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Bridgeport", "state": "Connecticut" }, { "city": "Weston", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00055497" }, { "nct_id": "NCT01674413", "title": "Calprotectin-Directed Humira® Maintenance Therapy (CADHUM)", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Crohn's Disease" ], "interventions": [ { "name": "Adalimumab", "type": "DRUG" }, { "name": "Adalimumab PRN", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Peter Higgins", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2013-10", "completion_date": "2016-03", "has_results": false, "last_update_posted_date": "2017-05-24", "last_synced_at": "2026-09-21T07:45:33.369Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT01674413" } ] }